Five Star Equities Issues New Research Reports on ALNY, GRPN, LULU and STJ


Follow this company

Companies Mentioned

NASDAQ:ALNY / NASDAQ:GRPN / NASDAQ:LULU / NYSE:STJ
01/14/2014 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares soared 40.89 percent to close at $93.28 a share Monday. The stock traded between $84.76 and $112.57 on volume 5.34 million shares traded. The company announced a $700.0 million investment by Sanofi's Genzyme as part of an expanded collaboration agreement. Shares of Alnylam Pharmaceuticals have gained approximately 360.0 percent in the past year.

Get more information on Alnylam Pharmaceuticals free access to the in-depth equity report at:  
www.FiveStarEquities.com/ALNY

Groupon Inc. (NASDAQ: GRPN) shares declined 5.02 percent to close at $10.98 a share Monday. The stock traded between $10.82 and $11.54 on volume 17.45 million shares traded. The company announced that it has acquired online flash fashion retailer Ideeli for $43.0 million in cash. Shares of Groupon have gained approximately 105.0 percent in the past year.

Get more information on Groupon and free access to the in-depth equity report at:  
www.FiveStarEquities.com/GRPN

Lululemon Athletica Inc. (NASDAQ: LULU) shares dropped 16.61 percent to close at $49.70 a share Monday. The stock traded between $49.00 and $51.75 on volume of 24.03 million shares traded. The company has lowered its fiscal fourth-quarter forecasts due to slowing traffic and sales trends in January. Shares of Lululemon Athletica have fallen approximately 30.0 percent in the past year.

Get more information on Lululemon Athletica and free access to the in-depth equity report at:  
www.FiveStarEquities.com/LULU

St. Jude Medical, Inc. (NYSE: STJ) shares increased 0.58 percent to close at $66.38 a share Monday. The stock traded between $66.21 and $68.39 on volume 4.27 million shares traded. The company announced that it expects net sales to be approximately $1.422 billion for the fourth quarter of 2013, an increase of 4.0 percent when compared to a year ago. Shares of St. Jude Medical have gained approximately 70.0 percent in the past year.

Get more information on St. Jude Medical and free access to the in-depth equity report at:  
www.FiveStarEquities.com/STJ

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:           
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *